glp 1 psoriatic arthritis Big news from the research side of One Rheumatology. Our clinical trial found encouraging improvements in patients with obesity when Taltz® was paired with GLP-1 therapy. This Treating Psoriatic Arthritis with GLP-1

It is an injectable treatment, employed alongside a proper diet and exercise, to assist in weight loss for those struggling with obesity

And how worrying it can be if you notice weight gain as a side effect

In the SURPASS 2 trial, Tirzepatide, at all doses (5mg, 10mg and 15mg) was more effective at lowering Hba1c and blood glucose levels compared to Semaglutide 1mg, aka Ozempic

If this wasnt enough motivation, recent reports indicate that there could be a PLI Scheme announced by the government in 2026, encouraging the manufacture of GLP-1 drugs

70 Notably, when the morphology of exenatide-induced neurites was evaluated alongside neurites generated by exposure to retinoic acid (RA), a well-characterized promoter of neurite outgrowth known to induce nuclear factor erythroid-derived 2 (Nrf2) upregulation, the overall morphology was similar to that of RA neurites